- Home
- VRAX
as 11-14-2024 9:48am EST
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes and Human Papillomavirus.
| Founded: | 2013 | Country: | United Kingdom |
| Employees: | N/A | City: | N/A |
| Market Cap: | 17.2M | IPO Year: | 2022 |
| Target Price: | N/A | AVG Volume (30 days): | 4.9M |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.36 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.60 - $9.00 | Next Earning Date: | 11-26-2024 |
| Revenue: | $156,419 | Revenue Growth: | 1727.11% |
| Revenue Growth (this year): | 5169.18% | Revenue Growth (next year): | 66.97% |
Latest Virax Biolabs Group Limited News
VRAX Breaking Stock News: Dive into VRAX Ticker-Specific Updates for Smart Investing
MT Newswires
23 days ago
Top Midday Gainers
PR Newswire
23 days ago
Virax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and Ireland
Benzinga
23 days ago
EXCLUSIVE: Virax Biolabs Inks Distribution Pact To Commercialize ImmuneSelect Profiling Solutions In UK And Ireland
MT Newswires
2 months ago
Cosmos Health Signs Deal to Distribute Virax Biolabs' Mpox PCR Detection Kits in India
MT Newswires
2 months ago
Virax Biolabs Extends Exclusive Distribution Deal for Mpox Virus Test Kits; Shares Rise Pre-Bell
PR Newswire
2 months ago
Virax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.
PR Newswire
2 months ago
Virax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment Conference
PR Newswire
3 months ago
Virax Biolabs to Participate at 7th European Congress of Immunology
Compare VRAX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRAX Virax Biolabs Group Limited - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.